NRP1 and brain glioma: These peptides are particularly valuable for their selective targeting capabilities through interactions with specific receptors on brain glioma tissue, and Neuropilin-1 (NRP-1), an overexpressed receptor on the surface of new blood vessels, could be a promising candidate for targeted drug delivery.